Adamantane - a lead structure for drugs in clinical practice
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023752%3A_____%2F16%3A43915056" target="_blank" >RIV/00023752:_____/16:43915056 - isvavai.cz</a>
Alternative codes found
RIV/60162694:G44__/16:43875645 RIV/00179906:_____/16:10329098
Result on the web
<a href="http://www.eurekaselect.com/142487/article" target="_blank" >http://www.eurekaselect.com/142487/article</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.2174/0929867323666160525114026" target="_blank" >10.2174/0929867323666160525114026</a>
Alternative languages
Result language
angličtina
Original language name
Adamantane - a lead structure for drugs in clinical practice
Original language description
The adamantane moiety is the structural backbone of numerous compounds and its discovery launched a new field of chemistry studying the approaches to the synthesis as well as the physicochemical and biological properties of organic polyhedral compounds with practical application in the pharmaceutical industry. Adamantane derivatives have proven to be very potent compounds in a wide range of applications from systemic to topical63 therapy. This review summarizes the currently available adamantane derivatives in clinical practice (amantadine, memantine, rimantadine, tromantadine, adapalene, saxagliptin, vildagliptin), focusing on mechanisms of action, pharmacokinetics, pharmacodynamics and clinical trials. The adamantane-based compounds presented in this manuscript have been approved for a wide spectrum of indications (antivirals, antidiabetics and against Alzheimer's and Parkinson's disease). Each of the compounds proved to be of vital importance in their therapeutic indication for numerous patients worldwide. This review also considers the mechanisms of side effects to deliver a complete perspective on current treatment options.
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FH - Neurology, neuro-surgery, nuero-sciences
OECD FORD branch
—
Result continuities
Project
Result was created during the realization of more than one project. More information in the Projects tab.
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Others
Publication year
2016
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Current Medicinal Chemistry
ISSN
0929-8673
e-ISSN
—
Volume of the periodical
23
Issue of the periodical within the volume
29
Country of publishing house
NL - THE KINGDOM OF THE NETHERLANDS
Number of pages
22
Pages from-to
3245-3266
UT code for WoS article
000387007800002
EID of the result in the Scopus database
2-s2.0-84996477477